2024 Signal Transduction by Engineered Extracellular Matrices Gordon Research Conference and Seminar
Project Number1R13EB035919-01
Contact PI/Project LeaderPEYTON, SHELLY R.
Awardee OrganizationGORDON RESEARCH CONFERENCES
Description
Abstract Text
Project Summary
The extracellular matrix (ECM) is a complex biopolymer network that defines the structure and mechanics of
solid tissue and can profoundly regulate cell function in development, physiology, and disease. As a result, there
has been an enormous effort to create biomaterials and other engineered systems that mimic the ECM with the
goal of modeling and controlling cell-ECM crosstalk for discovery and therapeutics. To promote continued
discovery and translation in this exciting field while nurturing the next generation of talent, we seek support for
the 2024 Gordon Research Conference (GRC) and Gordon Research Seminar (GRS) on Signal Transduction
by Engineered Extracellular Matrices (STEEM). The STEEM GRC/GRS is widely viewed as the premier venue
for sharing and discussing cutting-edge developments in ECM science and engineering. Over the past quarter-
century, STEEM has played a leadership role in bringing together biologists, engineers, materials scientists, and
other disciplinary experts into a common forum and has played a key role in incubating interdisciplinary topics
such as mechanobiology, biofabrication, and organoid technology. In the 2024 meeting, we will build on these
advances and explore several questions that will define the next decade of work in the field under the theme
Engineered microenvironments for next-generation biology, disease modeling, and therapeutics. The
GRC aims to: (1) Create a forum in which information and ideas are freely exchanged between researchers of
diverse and complementary backgrounds to enhance the potential of regenerative medicine and cell-based
therapies to improve human health; (2) Support a diverse group of young and early career investigators by
exposing them to new and exciting ideas and opportunities in an environment that encourages collegial
interactions; and (3) Bring together scientists across all experience levels, from trainees to senior scientists, and
representing diverse fields of expertise and professional settings from academic labs to national labs to small
and large biotechnology and pharmaceutical companies, to foster meaningful, long-lasting collaborations. The
GRS aims to: (1) Provide young and early career investigators, especially graduate students and postdoctoral
trainees, the opportunity to present their research in a forum organized by and for them; (2) Encourage lasting
collegial interactions and initiation of collaborations between young investigators of diverse fields; and (3) Provide
a unique opportunity for young scientists in the field to receive career guidance from selected faculty mentors
invited to the GRS.
Public Health Relevance Statement
Project Narrative
The 2024 Signal Transduction by Engineered Extracellular Matrices Gordon Research Conference (STEEM
GRC) will focus on the interface of biology and engineering and gather multidisciplinary scientists to disseminate
state-of-the-art research in highly active areas including single cell biology, multi-scale modeling,
mechanobiology, and engineered extracellular matrices (ECM) to investigate and control cell function. The
resulting multidisciplinary education will benefit our diverse colleagues as they advance our understanding of
how ECMs interface with cellular signaling networks, both in regenerative medicine and in understanding and
treating human disease.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
075712877
UEI
XL5ANMKWN557
Project Start Date
01-April-2024
Project End Date
31-March-2025
Budget Start Date
01-April-2024
Budget End Date
31-March-2025
Project Funding Information for 2024
Total Funding
$23,000
Direct Costs
$23,000
Indirect Costs
Year
Funding IC
FY Total Cost by IC
2024
National Institute on Aging
$4,000
2024
National Cancer Institute
$9,000
2024
National Institute of Biomedical Imaging and Bioengineering
$10,000
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R13EB035919-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R13EB035919-01
Patents
No Patents information available for 1R13EB035919-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R13EB035919-01
Clinical Studies
No Clinical Studies information available for 1R13EB035919-01
News and More
Related News Releases
No news release information available for 1R13EB035919-01
History
No Historical information available for 1R13EB035919-01
Similar Projects
No Similar Projects information available for 1R13EB035919-01